awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48623249-7872239D-ED8A-410B-B2F3-DFA1C8E5F2B7
Q48623249-7872239D-ED8A-410B-B2F3-DFA1C8E5F2B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48623249-7872239D-ED8A-410B-B2F3-DFA1C8E5F2B7
Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients.
P2860
Q48623249-7872239D-ED8A-410B-B2F3-DFA1C8E5F2B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48623249-7872239D-ED8A-410B-B2F3-DFA1C8E5F2B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8264c4e98f744c700d6ba95364e2439e29f242ef
P2860
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).